4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-037713
Chief Scientific Officer sold 4,000 shares at an average $67.05 ($268,182)
- Chief Scientific Officer acquired 4,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zago Wagner M. Chief Scientific Officer | 2023-08-02 | Option exercise 10b5-1 | +4,000 | $12.15 | $48,600 | 4,000 | D: show line 1 in the form |
| Zago Wagner M. Chief Scientific Officer | 2023-08-02 | Sale 10b5-1 | −3,771 | $66.98 | $252,593 | 229 | D: show line 2 in the form |
| Zago Wagner M. Chief Scientific Officer | 2023-08-02 | Sale 10b5-1 | −229 | $68.07 | $15,589 | 0 | D: show line 3 in the form |
| Open-market sales · 4,000 sh · avg $67.05 · $268,182 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Zago Wagner M. Chief Scientific Officer | 2023-08-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 58,000 | D: show line 4 in the form |
Loading xslF345X05/form4.xml…